# Arch Therapeutics, Inc. — Form D

Arch Therapeutics, Inc. of NATICK, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-10-05. The offering totals $2.0M, of which $75K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2010-10-05
- Form: D
- Accession: 0001502523-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $75K
- Remaining: $1.9M
- Investors: 2
- Date of first sale: 2010-09-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-148579

## Issuer

- Name: Arch Therapeutics, Inc.
- CIK: 0001502523
- Entity type: Corporation
- Jurisdiction: MASSACHUSETTS
- Incorporated: 2006
- Address: 1 CHIEFTAIN LANE, NATICK, MA, 01760
- Phone: 617-395-1397

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Steven W Kelly | Director | Natick, MA |
| James W Shannon | Director | Natick, MA |
| Michael W Bison | Executive Officer | Boston, MA |
| Steven W Kelly | Executive Officer | Natick, MA |
| ARTHUR W ROSENTHAL | Director | CAMBRIDGE, MA |
| AVTAR W DHILLON | Director | CAMBRIDGE, MA |
| TERRENCE W NORCHI | Director | CAMBRIDGE, MA |
| TERRENCE W NORCHI | Executive Officer | CAMBRIDGE, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2013-06-20](https://search.stillhousedata.com/formd/0001502523-13-000001) | D | $370K | $370K |

## More

- [CIK 1502523 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1502523&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001502523-10-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.